期刊文献+

不同负荷剂量氯吡格雷对植入药物洗脱支架患者术后影响 被引量:1

Effect of different loading dose of clopidogrel on implantation of the drug-eluting stent
下载PDF
导出
摘要 目的探讨药物洗脱支架(DES)植入后予不同剂量氯吡格雷的安全性及术后主要不良心脏事件(MACE)。方法176例接受DES植入患者随机进入氯吡格雷300、450、600、750mg负荷剂量组,术前6~24h服药,服药前及服药后4、24、48h监测血小板聚集率(PA),服药前、后24h监测血小板计数。临床随访6个月。结果氯吡格雷600、750mg组PA抑制明显,维持时间长,发生氯吡格雷抵抗病例少,MACE发生少;严重出血事件各组之间无差别,600、750mg组轻微出血事件增高,750mg组血小板计数明显下降。结论600、750mg组抑制PA效果更明显,作用时间更长,MACE发生更少;600mg负荷剂量优势更明显。 To observe the safety and major adverse cardiac event(MACE)of different loading dose of clopidogrel after implanting the drug eluting stent(DES).Methods One hundred and seventy-six patients were randomly divided into 4 groups according to the different loading dose of clopidogrel after DES implantation:300 mg(n=45),450 mg(n=41),600 mg(n=47)and 750 mg(n=43).Clopidogrel was administrated 6-24 h before DES implantation.Platelet aggregation(PA)was measured before and at 4,24,48 h after the drug administration.Platelet counts were measured before and at 24 hafter the drug administration.The patients were followed up for 6 months after operation.Results The time to the peak value of PA inhibition was lower in 600 mg and 750 mg groups than that in the other groups.The clopidogrel resistance was also lower in 600 mg and 750 mg groups.The MACE in 750 mg group was lower that than in the conventional loading dosage group(P〈0.05).Safety end points were similar in the 4 groups.But minor bleeding was high in the 600 mg and 750 mg groups.The platelet counts were decreased sharply in 750 mg loading dosage group.Conclusion Pretreatment with 750,600 mg loading dosage of clopidogrel 4 to 24 hours before the procedure can significantly reduce PA and maintain for a longer time with less occurrence of MACE.The 600 mg may be the best.
出处 《江苏医药》 CAS CSCD 北大核心 2007年第10期984-986,共3页 Jiangsu Medical Journal
基金 南京医科大学科技发展基金(06nmum059)
关键词 氯吡格雷 负荷剂量 药物涂层支架 Clopidogrel Loading dose Drug-eluting stent
  • 相关文献

参考文献9

  • 1Patti G,Colonna G,Pasceri V,et al.Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention:results from the ARMYDA-2 study[J].Circulation,2005,111(6):2099-2106.
  • 2Bertrand ME,Rupprecht HJ,Urban P,et al.Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting:the clopidogrel aspirin stent international cooperative study (CLASSICS)[J].Circulation,2000,102(6):624-629.
  • 3Bhatt DL,Bertrand ME,Berger PB,et al.Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting[J].J Am Coll Cardiol,2002,39(1):9 -14.
  • 4Braunwald E.Application of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarction[J].Circulation,2003,108(16 Suppl 1):Ⅲ28 -37.
  • 5Gorog P,Ridler CD,Rees GM,et al.Evidence against hypercoagulability in coronary artery disease[J].Thromb Res,1995,79(4):377-385.
  • 6Kaiser C,Brunner-La Rocca HP,Buser PT,et al.Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting:randomised Basel Stent Kosten Effektivitats Trial (BASKET)[J].Lancet,2005,366(9489):921-929.
  • 7Angiolillo D,Fernàndez-Ortiz A,Bernardo E,et al.High clopidogrel loading dose during coronary stenting:effects on drug response and interindividual variability[J].Eur Heart J,2004,25(21):1903-1910.
  • 8Williams D,Feely J.Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors[J].Clin Pharmacokinet,2002,41(5):343-370.
  • 9Wiviott SD,Antman EM.Clopidogrel resistance:a new chapter in a fast-moving story[J].Circulation,2004,109(25):3064-3067.

同被引文献24

  • 1朱永锋,李继福,李贵双,李静,张娣,朱媛媛,陈文强.国产和进口氯吡格雷对不稳定性心绞痛患者血小板功能的影响[J].中华老年心脑血管病杂志,2004,6(6):377-379. 被引量:19
  • 2杨艳敏,朱俊,谭慧琼,梁岩,章晏,李建东,刘力生,CREATE中国课题组.中国ST段抬高的急性心肌梗死临床特征及治疗现状[J].中华医学杂志,2005,85(31):2176-2182. 被引量:86
  • 3丁素菊,黎佳思,赵辉,毕晓莹.氯吡格雷对脑梗死患者血管内皮功能的影响[J].国外医学(脑血管疾病分册),2005,13(8):569-571. 被引量:8
  • 4霍勇,陈明.急性ST段抬高心肌梗死的抗栓与再灌注治疗[J].国际心血管病杂志,2006,33(3):143-146. 被引量:8
  • 5宗道然,陶贵周.急性ST段抬高心肌梗死治疗进展[J].中国心血管病研究,2007,5(9):717-720. 被引量:10
  • 6Yusuf S, Mehta SR, Xie C, et al. Effects of reviparin, a low molecule. weight heparin, on mortality, reinfarction, and strokes in patients wit1 acute myocardial infarction presenting with ST segment elevation[J]. JAMA, 2005, 293(4): 427-435.
  • 7De Luca G, Suryapranata H, Stone GW, et al. Abciximab as adjunctive therapy to reperfusion in acule ST-segment elevation myocardial infarction: a meta-analysis of randomized trials[J]. JAMA, 2005, 293 (14):1759-1765.
  • 8Hemandez AV, Westerhout CM, Steyerberg EW, et al. Effects of plateletglycoprotein II b/IIl a receptor blockers in non-ST segment elevation acute coronary syndromes:benefit and harm in different age subgroups[J]. Heart, 2007, 93(4):450-455.
  • 9Sulimov VA, Malova EV, Svrkin AL, et al. Effectiveness and safety of clopidogrel bisulfate in complex therapy of patients with acute coronary syndrome with STsegrnent devafion [J]. Kardiologiia, 2006, 46(7):26-32.
  • 10Sabatine MS, Cannon CP, Gibson CM, et al. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study [J]. JAMA, 2005, 94(10): 1224-1232.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部